Skip to main content

Table 2 Comparisons of embryo transfer cycle characteristics between two treatment approaches

From: Management of 14 patients with cornual heterotopic pregnancy following embryo transfer: experience from the past decade

 

All

(n = 14)

Treatment 1

(n = 6)

Treatment 2

(n = 8)

P value

Cycle number of embryo transfer

   

1.0

N = 1

4/28.6%

2/33.3%

2/25.0%

 

N = 2

6/42.9%

2/33.3%

4/50.0%

 

N ≥ 3

4/28.6%

2/33.3%

2/25.0%

 

Cycle type

   

0.277

 Fresh embryo transfer

6/42.9%

4/66.7%

2/25.0%

 

 Frozen embryo transfer

8/57.1%

2/33.3%

6/75.0%

 

Ovulation stimulation protocol

   

1.00

 GnRHa protocol

10/71.4%

4/66.7%

6/75.0%

 

 GnRHant protocol

4/28.6%

2/33.3%

2/25.0%

 

Endometrial preparation protocol in frozen embryo transfer

   

0.464

 NC

2/25.0%

1/16.7%

1/50.0%

 

 HRT

6/75.0%

5/83.3%

1/50.0%

 

No. of embryo for transfer

   

0.662

n = 1

1/7.1%

1/16.7%

0/0%

 

n = 2

13/92.9%

5/83.3%

8/100%

 

n = 3

0/0%

0/0%

0/0%

 

Embryo stage

   

0.755

 Cleavage

8/57.1%

4/66.7%

4/50.0%

 

 Morula

1/7.1%

0/0%

1/12.5%

 

 Blastocyst

5/35.7%

2/33.3%

3/37.5%

 

Gestational age at diagnosis (wk)

6.5 ± 0.55

6.5 ± 0.53

6.5 ± 0.55

1.0

  1. Abbreviation: GnRHa gonadotropin releasing hormone agonist, GnRHant gonadotropin releasing hormone antagonist, NC natural cycle, HRT hormone replacement therapy